{
    "Trade/Device Name(s)": [
        "IMMULITE 2500 Vitamin B12",
        "IMMULITE 2500 Folic Acid"
    ],
    "Submitter Information": "Diagnostic Products Corporation (DPC)",
    "510(k) Number": "K060929",
    "Predicate Device Reference 510(k) Number(s)": [
        "K993251",
        "K993254"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CDD",
        "CGN"
    ],
    "Summary Letter Date": "April 28, 2006",
    "Summary Letter Received Date": "April 5, 2006",
    "Submission Date": "April 4, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1810",
        "21 CFR 862.1295"
    ],
    "Regulation Name(s)": [
        "Vitamin B12 test system",
        "Folic Acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Vitamin B12",
        "Folic Acid"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Heparinized plasma",
        "Urine",
        "Ascorbic acid-treated whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE 2500 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent enzyme immunoassay"
    ],
    "Methodologies": [
        "Solid-phase two-site immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE 2500 Vitamin B12 and IMMULITE 2500 Folic Acid chemiluminescent immunoassays for use with the IMMULITE 2500 Analyzer.",
    "Indications for Use Summary": "For in vitro quantitative measurement of vitamin B12 in serum or heparinized plasma and folic acid in serum, heparinized plasma or ascorbic acid-treated whole blood, as aids in clinical diagnosis and treatment of anemia.",
    "fda_folder": "Clinical Chemistry"
}